Evidence map›Paper›PMID 28060226›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2017

Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa.

Ingrid V Bassett, Sharon M Coleman, Janet Giddy, Laura M Bogart, Christine E Chaisson, Douglas Ross, Moses J E Flash, Tessa Govender, Rochelle P Walensky, Kenneth A Freedberg and 1 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01188941 nacompletednot on this map

Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa

TypeinterventionalSponsorMassachusetts General HospitalRan2010 to 2015Enrolled1,899ConditionsHIVArmsHealth System Navigator
NCT06803316 completednot on this mapstarted 2022, after this paper: background citation

Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia

Typeobservational_patient_registrySponsorCentre for Infectious Disease Research in ZambiaRan2022 to 2025Enrolled658ConditionsHIV Antiretroviral Therapy (ART) Adherence
3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ingrid V Bassett*Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; †Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA; ‡Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA; §Harvard Medical School, Boston, MA; ‖Harvard University Center for AIDS Research, Harvard University, Boston, MA; ¶Data Coordinating Center, Boston University School of Public Health, Boston, MA; #McCord Hospital, Durban, South Africa; **Division of General Pediatrics, Department of Medicine, Boston Children's Hospital, Boston, MA; ††RAND Corporation, Santa Monica, CA; ‡‡St. Mary's Hospital, Durban, South Africa; §§Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; ‖‖Department of Epidemiology, Boston University School of Public Health, Boston, MA; ¶¶Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA; ##Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA; and ***Department of Biostatistics, Boston University School of Public Health, Boston, MA.
Sharon M Coleman
Janet Giddy
Laura M Bogart
Christine E Chaisson
Douglas Ross
Moses J E Flash
Tessa Govender
Rochelle P Walensky
Kenneth A Freedberg
Elena Losina

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
Optimizing HIV Care in Less Developed CountriesR01AI058736 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Kenneth Alan Freedberg, Emily Parker Hyle · 2004 to 2026
$21.5M
Novel Methods to Inform HIV/TB Clinical Trial DevelopmentR01AI093269 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI REDDY, KRISHNA P · 2011 to 2024
$6.8M
Novel Methods to Inform HIV/TB Clinical Trial DevelopmentR37AI093269 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALENSKY, ROCHELLE P. · 2015 to 2019
$3.8M
Linkage & Retention: A Randomized Trial to Optimize HIV/TB Care in South AfricaR01MH090326 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BASSETT, INGRID VALERIE · 2010 to 2014
$2.9M
What happens after diagnosis: Characterizing long-term HIV care trajectories and mortality in South AfricaR01MH108427 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BASSETT, INGRID VALERIE · 2016 to 2019
$1.7M
NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI058736NIAID NIH HHS R01 AI093269NIAID NIH HHS R37 AI093269NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH090326NIMH NIH HHS R01 MH108427
6 · The paper itself

Abstract

backgroundPrompt entry into HIV care is often hindered by personal and structural barriers. Our objective was to evaluate the impact of self-perceived barriers to health care on 1-year mortality among newly diagnosed HIV-infected individuals in Durban, South Africa.

methodsBefore HIV testing at 4 outpatient sites, adults (≥18 years) were surveyed regarding perceived barriers to care including (1) service delivery, (2) financial, (3) personal health perception, (4) logistical, and (5) structural. We assessed deaths via phone calls and the South African National Population Register. We used multivariable Cox proportional hazards models to determine the association between number of perceived barriers and death within 1 year.

resultsOne thousand eight hundred ninety-nine HIV-infected participants enrolled. Median age was 33 years (interquartile range: 27-41 years), 49% were females, and median CD4 count was 192/μL (interquartile range: 72-346/μL). One thousand fifty-seven participants (56%) reported no, 370 (20%) reported 1-3, and 460 (24%) reported >3 barriers to care. By 1 year, 250 [13%, 95% confidence interval (CI): 12% to 15%] participants died. Adjusting for age, sex, education, baseline CD4 count, distance to clinic, and tuberculosis status, participants with 1-3 barriers (adjusted hazard ratio: 1.49, 95% CI: 1.06 to 2.08) and >3 barriers (adjusted hazard ratio: 1.81, 95% CI: 1.35 to 2.43) had higher 1-year mortality risk compared with those without barriers.

conclusionsHIV-infected individuals in South Africa who reported perceived barriers to medical care at diagnosis were more likely to die within 1 year. Targeted structural interventions, such as extended clinic hours, travel vouchers, and streamlined clinic operations, may improve linkage to care and antiretroviral therapy initiation for these people.

Indexed as

AdultAnti-HIV AgentsCD4 Lymphocyte CountCoinfectionFemaleHealth Care SurveysHealth Services AccessibilityHIV InfectionsHumansLost to Follow-UpMalePatient ComplianceRandomized Controlled Trials as TopicSocial SupportSouth AfricaTuberculosisAnti-HIV Agents

Identifiers

PMID28060226
PMCPMC5321110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.